Poseida Therapeutics Statistics
Total Valuation
PSTX has a market cap or net worth of $245.71 million. The enterprise value is $85.73 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, after market close.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PSTX has 97.12 million shares outstanding. The number of shares has increased by 13.42% in one year.
| Shares Outstanding | 97.12M |
| Shares Change (YoY) | +13.42% |
| Shares Change (QoQ) | +0.98% |
| Owned by Insiders (%) | 6.82% |
| Owned by Institutions (%) | 49.45% |
| Float | 64.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.66 |
| Forward PS | 5.04 |
| PB Ratio | 3.94 |
| P/FCF Ratio | 1,131.54 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 404.38 |
Financial Position
The company has a current ratio of 2.48, with a Debt / Equity ratio of 1.38.
| Current Ratio | 2.48 |
| Quick Ratio | 2.44 |
| Debt / Equity | 1.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | 394.59 |
| Interest Coverage | -13.14 |
Financial Efficiency
Return on equity (ROE) is -115.00% and return on invested capital (ROIC) is -40.37%.
| Return on Equity (ROE) | -115.00% |
| Return on Assets (ROA) | -25.54% |
| Return on Capital (ROIC) | -40.37% |
| Revenue Per Employee | $268,067 |
| Profits Per Employee | -$341,733 |
| Employee Count | 330 |
| Asset Turnover | 0.31 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PSTX has paid $107,000 in taxes.
| Income Tax | 107,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.27% in the last 52 weeks. The beta is 0.54, so PSTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +3.27% |
| 50-Day Moving Average | 2.75 |
| 200-Day Moving Average | 2.98 |
| Relative Strength Index (RSI) | 47.23 |
| Average Volume (20 Days) | 397,470 |
Short Selling Information
The latest short interest is 4.81 million, so 4.96% of the outstanding shares have been sold short.
| Short Interest | 4.81M |
| Short Previous Month | 4.54M |
| Short % of Shares Out | 4.96% |
| Short % of Float | 7.48% |
| Short Ratio (days to cover) | 8.14 |
Income Statement
In the last 12 months, PSTX had revenue of $88.46 million and -$112.77 million in losses. Loss per share was -$1.19.
| Revenue | 88.46M |
| Gross Profit | -68.32M |
| Operating Income | -118.47M |
| Pretax Income | -112.67M |
| Net Income | -112.77M |
| EBITDA | -112.86M |
| EBIT | -118.47M |
| Loss Per Share | -$1.19 |
Full Income StatementBalance Sheet
The company has $237.81 million in cash and $83.65 million in debt, giving a net cash position of $154.16 million or $1.59 per share.
| Cash & Cash Equivalents | 237.81M |
| Total Debt | 83.65M |
| Net Cash | 154.16M |
| Net Cash Per Share | $1.59 |
| Equity (Book Value) | 60.82M |
| Book Value Per Share | 0.63 |
| Working Capital | 151.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.46 million and capital expenditures -$2.25 million, giving a free cash flow of $212,000.
| Operating Cash Flow | 2.46M |
| Capital Expenditures | -2.25M |
| Free Cash Flow | 212,000 |
| FCF Per Share | $0.00 |
Full Cash Flow StatementMargins
Gross margin is -77.23%, with operating and profit margins of -133.92% and -127.48%.
| Gross Margin | -77.23% |
| Operating Margin | -133.92% |
| Pretax Margin | -127.36% |
| Profit Margin | -127.48% |
| EBITDA Margin | -127.58% |
| EBIT Margin | -133.92% |
| FCF Margin | 0.24% |
Dividends & Yields
PSTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.42% |
| Shareholder Yield | -13.42% |
| Earnings Yield | -47.01% |
| FCF Yield | 0.09% |
Analyst Forecast
The average price target for PSTX is $15.00, which is 492.89% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 492.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 29.65% |
| EPS Growth Forecast (5Y) | -35.07% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PSTX has an Altman Z-Score of -2.8 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.8 |
| Piotroski F-Score | 2 |